Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma

Oncogene

Volumn 32, Issue 11, 2013, Pages 1469-1474

  Du, W ^a   Wright, B M ^a   Li, X ^a   Finke, J ^b   Rini, B I ^b   Zhou, M ^c   He, H ^c   Lal, P ^d   Welford, S M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Molecular Medicine ^*  (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

autocrine signaling; macrophage migration inhibitory factor; MIF; p27; renal cell carcinoma; src

Indexed keywords

CD44V ANTIGEN; CD74 ANTIGEN; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE P60; PROTEIN P27; SHORT HAIRPIN RNA;

ARTICLE; AUTOCRINE EFFECT; CANCER TISSUE; CONTROLLED STUDY; GROWTH RATE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SURVIVAL; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; AUTOCRINE COMMUNICATION; CARCINOMA, RENAL CELL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMANS; KIDNEY NEOPLASMS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, NUDE; PROGNOSIS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84875220714     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.143     Document Type: Article

References (36)

1. American Cancer Society. Cancer Facts & Figures 2011. Atlanta, Ga: American Cancer Society, 2011.
2. Kaelin Jr. WG, Ratcliffe PJ. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell 2008; 30: 393-402. (Pubitemid 351681994)
3. Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin WG. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 2002; 1: 237-246. (Pubitemid 41039148)
4. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol 2004; 22: 4991-5004. (Pubitemid 46646218)
5. Bach JP, Rinn B, Meyer B, Dodel R, Bacher M. Role of MIF in inflammation and tumorigenesis. Oncology 2008; 75: 127-133.
6. David Jr. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966; 56: 72-77.
7. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377: 68-71.
8. Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 2007; 26: 5046-5059. (Pubitemid 47206949)
9. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000; 408: 211-216.
10. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M et al. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal 2006; 18: 688-703. (Pubitemid 43113299)
11. Amin MA, Haas CS, Zhu K, Mansfield PJ, Kim MJ, Lackowski NP et al. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 2006; 107: 2252-2261. (Pubitemid 43345542)
12. Bacher M, Schrader J, Thompson N, Kuschela K, Gemsa D, Waeber G et al. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am J Pathol 2003; 162: 11-17. (Pubitemid 36041985)
13. Baugh JA, Gantier M, Li L, Byrne A, Buckley A, Donnelly SC. Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun 2006; 347: 895-903. (Pubitemid 44118203)
14. Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000; 60: 883-887. (Pubitemid 30129520)
15. Welford SM, Bedogni B, Gradin K, Poellinger L, Broome Powell M, Giaccia AJ. HIF1alpha delays premature senescence through the activation of MIF. Genes Dev 2006; 20: 3366-3371. (Pubitemid 44969155)
16. He XX, Yang J, Ding YW, Liu W, Shen QY, Xia HH. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis. Gut 2006; 55: 797-802. (Pubitemid 43764549)
17. Hira E, Ono T, Dhar DK, El-Assal ON, Hishikawa Y, Yamanoi A et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer 2005; 103: 588-598.
18. Meyer-Siegler KL, Bellino MA, Tannenbaum M. Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma. Cancer 2002; 94: 1449-1456. (Pubitemid 34212639)
19. He XX, Chen K, Yang J, Li XY, Gan HY, Liu CY et al. Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med 2009; 15: 1-10.
20. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun 1999; 264: 751-758.
21. Kamimura A, Kamachi M, Nishihira J, Ogura S, Isobe H, Dosaka-Akita H et al. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer 2000; 89: 334-341. (Pubitemid 30489881)
22. Xia HH, Yang Y, Chu KM, Gu Q, Zhang YY, He H et al. Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer. Cancer 2009; 115: 5441-5449.
23. Legendre H, Decaestecker C, Nagy N, Hendlisz A, Schuring MP, Salmon I et al. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod Pathol 2003; 16: 491-504. (Pubitemid 36618470)
24. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003; 197: 1467-1476. (Pubitemid 36686708)
25. Shi X, Leng L, Wang T, Wang W, Du X, Li J et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006; 25: 595-606. (Pubitemid 44529040)
26. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007; 13: 587-596. (Pubitemid 46828480)
27. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygendependent proteolysis. Nature 1999; 399: 271-275. (Pubitemid 29246458)
28. Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH. Up-regulation of hypoxiainducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 2000; 19: 5435-5443. (Pubitemid 32000910)
29. Lubetsky JB, Dios A, Han J, Aljabari B, Ruzsicska B, Mitchell R et al. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J Biol Chem 2002; 277: 24976-24982. (Pubitemid 34951799)
30. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002; 99: 345-350. (Pubitemid 34060365)
31. Nguyen MT, Lue H, Kleemann R, Thiele M, Tolle G, Finkelmeier D et al. The cytokine macrophage migration inhibitory factor reduces pro-oxidative stressinduced apoptosis. J Immunol 2003; 170: 3337-3347. (Pubitemid 36302213)
32. Li GQ, Xie J, Lei XY, Zhang L. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway. World J Gastroenterol 2009; 15: 5541-5548.
33. Schrader J, Deuster O, Rinn B, Schulz M, Kautz A, Dodel R et al. Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown. BMC Cancer 2009; 9: 464.
34. Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 2002; 277: 7865-7874. (Pubitemid 34968235)
35. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S et al. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 2007; 128: 281-294. (Pubitemid 46123510)
36. Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE et al. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 2008; 14: 435-446.